A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX…
Verified by: Azaya Therapeutics, Inc., October 2012
First Received: October 19, 2012 | Last Updated: October 24, 2012
Phase: Phase 1 | Start Date: October 2012
Overall Status: Recruiting | Estimated Enrollment: 40
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.